Patients in the ER are getting mobile ads from law firms that notice when the consumers are there and cancer patients are receiving marketing about pharmaceuticals that can target their specific genetic codes. How much data is too much, creating TMI healthcare marketing? Here are two tips to help healthcare marketers navigate that regulatory minefield.
Cancer Patients Can Get Targeted Marketing, But Be Careful
As a June 1 article in Nature points out, new pharmaceuticals may be able to pinpoint, for instance, a tumor’s genetic anomalies and target them for pinpoint treatment — minimizing side effects.
